Company / Current Liabilities per Share
Inhibrx Biosciences, Inc. Current Liabilities per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.33
FY2025
5-year range
$0.86 / $4.78
FY2023-FY2025
Trend
+171.5%
vs FY2024
Sector context
#64 of 210
Health Care
What the data says
At $2.33, Inhibrx Biosciences, Inc.'s current liabilities per share ranks #147 of 210 in the Health Care sector. Improved from $4.78 to $2.33 over the past 2 years.
Based on SEC 10-K filings.
2.33 in FY2025.
Improved from $4.78 to $2.33 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#147 of 210 in Health CareTop 70% of 210This company $2.33 Sector average $23.79
▼
-90.2% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 171.5% year-over-year.
- Ranks #64 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.33 | +171.5% |
| FY2024 | $0.86 | -82.0% |
| FY2023 | $4.78 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026